Quantinuum Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	29.31	30.93	22.98
Revenue Growth	-	34.61%	-
Cost of Revenue	15.62	4.73	10.81
Gross Profit	13.69	26.2	12.17
Selling, General & Admin	261.71	48.72	31.33
Research & Development	567.03	165.42	122.24
Amortization of Goodwill & Intangibles	15.39	11.36	11.36
Operating Expenses	844.13	225.5	164.93
Operating Income	-830.45	-199.3	-152.75
Interest & Investment Income	31.07	12.68	10.03
Other Non Operating Income (Expenses)	-102.79	-3.97	-1.11
EBT Excluding Unusual Items	-902.16	-190.59	-143.84
Legal Settlements	-1.9	-1.9	-
Pretax Income	-904.06	-192.49	-143.84
Income Tax Expense	0.02	0.08	0.23
Net Income	-382.17	-192.56	-144.07
Net Income to Common	-382.17	-192.56	-144.07
Net Income Growth	-	-	-
Shares Outstanding (Basic)	43	300	300
Shares Outstanding (Diluted)	43	300	300
Shares Change	-	-	-
EPS (Basic)	-8.82	-0.64	-0.48
EPS (Diluted)	-8.82	-0.64	-0.48
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-362.09	-225.35	-134.89
Free Cash Flow Per Share	-8.36	-0.75	-0.45
Gross Margin	46.70%	84.71%	52.97%
Operating Margin	-2833.51%	-644.32%	-664.75%
Profit Margin	-1303.97%	-622.55%	-626.97%
Free Cash Flow Margin	-1235.45%	-728.56%	-587.02%
EBITDA	-795.55	-169.82	-121.33
D&A For EBITDA	34.9	29.48	31.43
EBIT	-830.45	-199.3	-152.75

SEC Filings: 10-K · 10-Q